doxifluridine

dihydropyrimidine dehydrogenase ; Homo sapiens







22 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 23229803 Predictive markers of capecitabine sensitivity identified from the expression profile of pyrimidine nucleoside-metabolizing enzymes. 2013 Feb 2
2 22480411 The effect of chemotherapy or radiotherapy on thymidine phosphorylase and dihydropyrimidine dehydrogenase expression in cancer of the uterine cervix. 2012 Jul 1
3 19117293 The predictive and therapeutic value of thymidine phosphorylase and dihydropyrimidine dehydrogenase in capecitabine (Xeloda)-based chemotherapy for head and neck cancer. 2009 Jan 1
4 18630517 Changes of gene expression of thymidine phosphorylase, thymidylate synthase, dihydropyrimidine dehydrogenase after the administration of 5'-deoxy-5-fluorouridine, paclitaxel and its combination in human gastric cancer xenografts. 2008 May-Jun 1
5 17629045 Pyrimidine nucleoside phosphorylase and dihydropyrimidine dihydrogenase activities as predictive factors for the efficacy of doxifluridine together with mitomycin C as adjuvant chemotherapy in primary colorectal cancer. 2007 Jun 2
6 16353181 Upregulation of thymidine phosphorylase in rectal cancer tissues by mitomycin C. 2006 Jan 1 4
7 15729713 Development of a stereological method to measure levels of fluoropyrimidine metabolizing enzymes in tumor sections using laser scanning cytometry. 2005 Apr 1
8 15944764 Correlations between antitumor activities of fluoropyrimidines and DPD activity in lung tumor xenografts. 2005 Jul 1
9 14614573 Thymidine phosphorylase expression is preserved after radiotherapy in patients with cervical squamous cell carcinoma. 2004 Feb 1
10 15114696 [Estimation of level of enzyme induction of thymidine phosphorylase, dihydropyrimidine dehydrogenase, and thymidylate synthase in primary and recurrent breast cancer]. 2004 Apr 2
11 15196541 The ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase in tumour tissues of patients with metastatic gastric cancer is predictive of the clinical response to 5'-deoxy-5-fluorouridine. 2004 Jul 4
12 15628771 [Significance of tissue thymidine phosphorylase and dihydropyrimidine dehydrogenase activities in ovarian cancer]. 2004 Dec 1
13 12931018 Quantitative analysis of thymidine phosphorylase and dihydropyrimidine dehydrogenase in renal cell carcinoma. 2003 1
14 14518422 [PyNPase and DPD expression potentially predict response to 5'-DFUR treatment for node-positive breast cancer patients]. 2003 Sep 5
15 14641294 High level concentration of pyrimidine nucleoside phosphorylase in esophageal squamous cell carcinoma but no correlation with clinicopathological parameters. 2003 2
16 11956613 Thymidine phosphorylase and dihydropyrimidine dehydrogenase levels in primary colorectal cancer show a relationship to clinical effects of 5'-deoxy-5-fluorouridine as adjuvant chemotherapy. 2002 May-Jun 3
17 12460781 Role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in tumour progression and sensitivity to doxifluridine in gastric cancer patients. 2002 Dec 6
18 11302344 Clinical relevance of the concentrations of both pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer. 2001 Feb 5
19 11383213 [Significance of pyrimidine nucleoside phosphorylase (PyNPase) and dihydropyrimidine dehydrogenase (DPD) in advanced gastric cancers]. 2001 May 1
20 10853015 Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues. 2000 Jul 6
21 11810506 Pyrimidine nucleoside phosphorylase and dihydropyrimidine dehydrogenase indicate chemosensitivity of human colon cancer specimens to doxifluridine and 5-fluorouracil, respectively. 1999 Sep 2
22 9485021 Positive correlation between the efficacy of capecitabine and doxifluridine and the ratio of thymidine phosphorylase to dihydropyrimidine dehydrogenase activities in tumors in human cancer xenografts. 1998 Feb 15 2